4 Long COVID Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Long COVID Studies in San Francisco

NCT06631287Recruiting

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertio...

San Francisco, CAPHASE3550 participantsWes Ely

View Study Details

NCT07770022Recruiting

Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)

The purpose of this study is to better understand the biological changes associated with Long COVID and to identify laboratory tests (biomarkers) that may help diagnose the condition and measure how i...

San Francisco, CA150 participantsUniversity of California, San Francisco

View Study Details

NCT07076862Recruiting

Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)

This study uses total-body \[¹⁸F\]F-AraG PET/CT imaging to investigate immune activation and vascular changes in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC), also known as Long...

San Francisco, CAEARLY_PHASE151 participantsUniversity of California, Davis

View Study Details

NCT07108036Recruiting

A Study to Assess Anktiva in Patients With Long Covid-19.

This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and have follow-up exams and tests....

San Francisco, CAPHASE220 participantsImmunityBio, Inc.

View Study Details

About Long COVID Clinical Trials in San Francisco

Long COVID (post-acute sequelae of SARS-CoV-2) refers to symptoms persisting weeks to months after the initial COVID-19 infection. Symptoms can include fatigue, brain fog, breathlessness, and joint pain. Research is actively investigating causes and treatments for this complex condition.

There are currently 4 long covid clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 771 participants. Research is being sponsored by Wes Ely, University of California, San Francisco, University of California, Davis and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Long COVID Clinical Trials in San Francisco — FAQ

Are there long covid clinical trials in San Francisco?

Yes, there are 4 long covid clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What long covid treatments are being tested?

The 4 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for long covid.

Data updated October 16, 2026 from ClinicalTrials.gov